Harmony Biosciences Holdings, Inc. (HRMY)

NASDAQ: HRMY · Real-Time Price · USD

28.19

+1.32 (4.91%)

At close: Feb 24, 2026, 4:00 PM EST

28.75

+0.56 (1.99%)

After-hours: Feb 24, 2026, 7:38 PM EST

HRMY Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	868.45	714.73	582.02	437.86	305.44
Revenue Growth (YoY)	21.51%	22.80%	32.93%	43.35%	91.21%
Cost of Revenue	198.34	156.82	121.24	83.48	55.52
Gross Profit	670.11	557.92	460.79	354.37	249.92
Selling, General & Admin	272.05	221.27	192.69	163.3	132.03
Research & Development	189.59	145.83	76.06	70.89	30.37
Operating Expenses	461.64	367.09	268.76	234.19	162.39
Operating Income	208.47	190.83	192.03	120.19	87.53
Interest Expense	-14.65	-17.5	-23.76	-18.8	-24.19
Interest & Investment Income	21.92	18.54	14.73	3.13	0.22
Other Non Operating Income (Expenses)	-0.68	-0.07	0.16	0.17	0.02
EBT Excluding Unusual Items	215.06	191.8	183.16	104.69	63.57
Other Unusual Items	-	-	-9.77	-	-26.15
Pretax Income	215.06	191.8	173.4	104.69	37.43
Income Tax Expense	56.38	46.31	44.54	-76.78	2.83
Net Income	158.69	145.49	128.85	181.47	34.6
Net Income to Common	158.69	145.49	128.85	181.47	34.6
Net Income Growth	9.07%	12.91%	-28.99%	424.52%	-
Shares Outstanding (Basic)	57	57	59	59	58
Shares Outstanding (Diluted)	59	58	60	61	59
Shares Change (YoY)	1.17%	-4.15%	-1.19%	3.19%	129.72%
EPS (Basic)	2.76	2.56	2.17	3.07	0.60
EPS (Diluted)	2.71	2.51	2.13	2.97	0.58
EPS Growth	7.97%	17.84%	-28.28%	412.07%	-
Free Cash Flow	347.89	218.67	219.08	144.29	98.26
Free Cash Flow Per Share	5.94	3.78	3.63	2.36	1.66
Gross Margin	77.16%	78.06%	79.17%	80.93%	81.82%
Operating Margin	24.01%	26.70%	32.99%	27.45%	28.66%
Profit Margin	18.27%	20.36%	22.14%	41.45%	11.33%
Free Cash Flow Margin	40.06%	30.59%	37.64%	32.95%	32.17%
EBITDA	233.8	214.94	216.39	143.57	106.37
EBITDA Margin	26.92%	30.07%	37.18%	32.79%	34.83%
D&A For EBITDA	25.34	24.11	24.36	23.39	18.84
EBIT	208.47	190.83	192.03	120.19	87.53
EBIT Margin	24.01%	26.70%	32.99%	27.45%	28.66%
Effective Tax Rate	26.21%	24.14%	25.69%	-	7.56%
Advertising Expenses	-	27.56	21.54	22.43	19.56

Updated Feb 24, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q